|
Group Health/University of Washington CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Group Health/University of Washington |
Case, Control |
300 |
4,475 |
96%, 100% |
|
|
Columbia - Hearing Loss |
Hearing Loss |
Columbia University Medical Center |
Case, Control |
97 |
2,334 |
|
|
|
Marshfield implementation |
caMRSA |
Marshfield Clinic Research Foundation |
Case, Control |
|
|
100%, 100% |
100%, 100% |
|
CHOP |
Type 1 Diabetes |
CHOP |
Case, Control |
|
|
|
|
|
AAA Implementation - Columbia |
Abdominal Aortic Aneurysm ( AAA ) |
Columbia University |
Case, Control |
10 |
1,354 |
|
|
|
CRS merged all sites |
CRS (Chronic Rhinosinusitis) |
|
Case, Control |
|
|
|
|
|
CHOP Depression |
Depression |
|
Case, Control |
|
|
|
|
|
CDiff Implementation - Columbia |
Clostridium Difficile Colitis |
Columbia University |
Case, Control |
107 |
139 |
|
|
|
Harvard Implementation |
Appendicitis |
|
Case, Control |
877 |
771 |
|
|
|
Columbia Implementation |
Pneumonia- VUMC eMERGE v5.1 |
Columbia University |
Case, Control |
156 |
8,015 |
96% |
|
|
Marshfield Implementation 2 |
CAAD (Carotid Artery Atherosclerosis Disease) |
Marshfield Clinic Research Foundation |
Case, Control |
193 |
4,170 |
100%, 100% |
|
|
Geisinger Implementation |
Hearing Loss |
Geisinger |
Case, Control |
336 |
6,479 |
|
|
|
Geisinger caMRSA Implementation |
caMRSA |
Geisinger |
Case, Control |
25 |
25 |
96%, 100% |
96% |
|
MGB |
Type 1 Diabetes |
|
Case, Control |
|
|
|
|
|
Marshfield Venous Thromboembolism implementation |
Venous Thromboembolism (VTE) |
Marshfield Clinic Research Foundation |
Case, Control |
50 |
49 |
98%, 100% |
|
|
NU depression data |
Depression |
Northwestern University |
Case, Control |
|
|
|
|
|
Geisinger c.Diff eMERGE3 Implementation |
Clostridium Difficile Colitis |
Geisinger |
Case, Control |
20 |
20 |
100%, 100% |
100%, 100% |
|
GH/UW Implementation |
Appendicitis |
|
Case, Control |
0 |
1,761 |
|
|
|
Marshfield Implementation |
Pneumonia- VUMC eMERGE v5.1 |
Marshfield Clinic Research Institute |
Case, Control |
|
|
|
|
|
Mayo Clinic CAAD Evaluation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mayo Clinic |
Case, Control |
|
|
100% |
72% |
|
Mayo clinic hearing loss implementation |
Hearing Loss |
Mayo Clinic |
Case, Control |
|
|
|
|
|
Vanderbilt Implementation of caMRSA |
caMRSA |
Vanderbilt University |
Case, Control |
262 |
2,313 |
|
|
|
NU T1DM PRS implementation |
Type 1 Diabetes |
Northwestern University |
Case, Control |
63 |
3,632 |
|
|
|
Venous Thromboembolism Implementation - Columbia |
Venous Thromboembolism (VTE) |
Columbia University |
Case, Control |
419 |
2,574 |
|
|
|
CHOP eMERGE III |
Migraine |
CHOP |
Case, Control |
|
|
|
|
